Guerra Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Guerra Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$10K	Buy	+138	New	+$9.52K	﹤0.01%	311

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Guerra Advisors's IHE Position: Q3 2025 in Review

Guerra Advisors opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2025: 138 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #311 among its holdings.

149 funds tracked by Wall St. Rank hold IHE as of Q3 2025.

Guerra Advisors held 138 shares of iShares US Pharmaceuticals ETF worth $10K as of Q3 2025.
iShares US Pharmaceuticals ETF was a new Guerra Advisors position in Q3 2025.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #311 holding.
149 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.